linnea_wahlberg
I keep a spreadsheet. It has opinions.
17kreputation
41answers
6accepted
19questions
0·2·7badges g·s·b
49tags
170Is 5 mg/mL a sensible working concentration for retatrutide, or should I go lower?accepted · answered 2 Sept 2024 · diluent-volume, reconstitution, dosing-math73Does oxidation dominate for liraglutide held at minus 80 °C?answered 22 Jul 2024 · peptide-stability, storage, hplc72Can I reconstitute cagrilintide at 10 mg/mL and still measure a small dose accurately?answered 3 Sept 2025 · diluent-volume, insulin-syringe, dosing-math70What is the arithmetic to convert 10 mg in 3 mL into units on a U-100 scale?answered 26 Aug 2024 · dosing-math, insulin-syringe, reconstitution58How do I get 25 units out of a vial reconstituted to 6.67 mg/mL without guessing?answered 2 Jan 2025 · insulin-syringe, dosing-math, diluent-volume50How many vial-days does a 60 mg vial give at 20 mg/mL on a weekly schedule?answered 22 Sept 2024 · dosing-math, cost-analysis, diluent-volume49Can I reconstitute oral semaglutide at 10 mg/mL and still measure a small dose accurately?accepted · answered 21 Oct 2024 · diluent-volume, insulin-syringe, dosing-math49How many vial-days does an 8 mg vial give at 4 mg/mL on a weekly schedule?answered 11 Oct 2024 · dosing-math, cost-analysis, diluent-volume41If I reconstitute a 10 mg vial with 1 mL of 0.9% sodium chloride, what concentration do I end up with?accepted · answered 14 Apr 2025 · reconstitution, diluent-volume, dosing-math36If I reconstitute a 20 mg vial with 2.5 mL of bacteriostatic water, what concentration do I end up with?accepted · answered 12 Jun 2024 · reconstitution, diluent-volume, dosing-math36What is the arithmetic to convert 20 mg in 3 mL into units on a U-100 scale?answered 1 Feb 2025 · dosing-math, insulin-syringe, reconstitution34Is 20 mg in 1 mL of bacteriostatic water a sensible presentation for liraglutide?answered 2 Feb 2025 · diluent-volume, reconstitution, dosing-math34Is 20 mg in 2.5 mL of bacteriostatic water a sensible presentation for oral semaglutide?answered 13 Jan 2026 · diluent-volume, reconstitution, dosing-math34Is a 99.1% result from Medutest comparable to 95.2% from PeptideMeter?answered 11 Mar 2025 · purity, batch-testing, reference-standard34Why is my second draw from the same vial reading a different volume?answered 12 Oct 2024 · insulin-syringe, dead-space, dosing-math32How do I get 8 units out of a vial reconstituted to 2 mg/mL without guessing?answered 7 Aug 2024 · insulin-syringe, dosing-math, diluent-volume30What is the dead-space loss per draw with a 30G needle at 8 mg/mL?answered 24 Aug 2025 · dead-space, insulin-syringe, dosing-math29Is 3.33 mg/mL a sensible working concentration for ecnoglutide, or should I go lower?accepted · answered 4 Nov 2025 · diluent-volume, reconstitution, dosing-math28How do I get 10 units out of a vial reconstituted to 1 mg/mL without guessing?accepted · answered 1 Jan 2025 · insulin-syringe, dosing-math, diluent-volume27How do I compare Homopeptide and GGPeps on lead time to the United Kingdom?answered 7 Feb 2026 · vendor-comparison, international-shipping, cold-chain25How do I get 4 units out of a vial reconstituted to 5 mg/mL without guessing?answered 6 Jul 2026 · insulin-syringe, dosing-math, diluent-volume24Is an 18G drawing needle the right choice for drawing retatrutide at 20 mg/mL?answered 15 Nov 2025 · needle-gauge, injection-technique, dead-space23Does swirling versus inverting a vial make any measurable difference?answered 14 Jul 2026 · reconstitution, peptide-stability, injection-technique20How do I compute the +5 charge state m/z for a peptide of 4813.5 Da?answered 12 Oct 2024 · mass-spec, dosing-math, purity18What is the arithmetic to convert 30 mg in 1.5 mL into units on a U-100 scale?answered 14 Jan 2026 · dosing-math, insulin-syringe, reconstitution17How many vial-days does a 2.5 mg vial give at 5 mg/mL on a weekly schedule?answered 26 Feb 2025 · dosing-math, cost-analysis, diluent-volume16Can I reconstitute retatrutide at 5 mg/mL and still measure a small dose accurately?answered 2 Jul 2026 · diluent-volume, insulin-syringe, dosing-math16Is 3.33 mg/mL a sensible working concentration for dulaglutide, or should I go lower?answered 13 Dec 2025 · diluent-volume, reconstitution, dosing-math16Is 40 mg in 2 mL of 0.9% sodium chloride a sensible presentation for a GLP-1 receptor agonist?answered 27 Oct 2025 · diluent-volume, reconstitution, dosing-math15How many vial-days does a 4 mg vial give at 2.5 mg/mL on a weekly schedule?answered 20 Sept 2025 · dosing-math, cost-analysis, diluent-volume15How many vial-days does an 8 mg vial give at 10 mg/mL on a weekly schedule?answered 12 Oct 2024 · dosing-math, cost-analysis, diluent-volume14What does SURMOUNT-3 report at the 10 mg dose level?answered 8 Jul 2026 · clinical-trials, dosing-math, titration13What is the arithmetic to convert 20 mg in 2 mL into units on a U-100 scale?answered 1 Nov 2024 · dosing-math, insulin-syringe, reconstitution12Is 1 mg/mL a sensible working concentration for oral semaglutide, or should I go lower?answered 6 Apr 2025 · diluent-volume, reconstitution, dosing-math11How do I check my dose arithmetic without trusting a website calculator?answered 25 Jun 2024 · dosing-math, harm-reduction, insulin-syringe9If I reconstitute a 15 mg vial with 3 mL of phosphate-buffered diluent, what concentration do I end up with?answered 12 Apr 2026 · reconstitution, diluent-volume, dosing-math6Can I reconstitute orforglipron at 5 mg/mL and still measure a small dose accurately?answered 10 Jul 2026 · diluent-volume, insulin-syringe, dosing-math4How do I get 4 units out of a vial reconstituted to 2 mg/mL without guessing?answered 19 Aug 2025 · insulin-syringe, dosing-math, diluent-volume3How do I compare SSA and HJ on lead time to Canada?answered 28 Jul 2026 · vendor-comparison, international-shipping, cold-chain2Is 5 mg/mL a sensible working concentration for survodutide, or should I go lower?answered 31 Jan 2025 · diluent-volume, reconstitution, dosing-math1What should be in place before a first orforglipron vial arrives from Qingdao?answered 23 Jan 2025 · harm-reduction, research-use-only, sterility